This post was originally published on this site
Conformis, Inc. (CFMS) 13% HIGHER; announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for the Companys Actera Hip System.
POINT Biopharma Global Inc. (PNT) 8% LOWER; announced that it has commenced an underwritten public offering of its common stock.
Starbucks (NASDAQ:SBUX) 3% HIGHER; sees 15-20% adjusted EPS growth in FY23-FY25
Flowserve Corporation (NYSE:FLS) 2% LOWER; said per events are expected to negatively impact our reported and adjusted EPS by 18 to 22 cents in the 2022 third quarter.
Akero Therapeutics, Inc. (Nasdaq: NASDAQ:AKRO) 1% LOWER; commenced an underwritten public offering of $175.0 million of shares of its common stock.
